A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.

scientific article

A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBMT.2011.07.017
P698PubMed publication ID21801703
P5875ResearchGate publication ID51533002

P50authorSimon F LaceyQ56978267
P2093author name stringPaul Frankel
Robert Chen
Stephen J Forman
David Snyder
Ryotaro Nakamura
Andrew Dagis
Leslie Popplewell
Auayporn Nademanee
Maria Delioukina
Anthony S Stein
Mark H Kirschbaum
Joel Conrad
P433issue3
P304page(s)432-440
P577publication date2011-07-27
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titleA phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.
P478volume18

Reverse relations

cites work (P2860)
Q41474323Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial.
Q35770734Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant
Q26824498Fifty years of melphalan use in hematopoietic stem cell transplantation
Q88778743Fludarabine and neurotoxicity in engineered T-cell therapy
Q47903276Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT.
Q38351859New drug toxicities in the onco-nephrology world
Q36176670Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation
Q38488058Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation
Q38202155Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis
Q36036328Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial
Q40460438Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT.

Search more.